Breaking news on Allergy
Immune System Pathway Identified To Fight Allergens, Asthma published
Thu, 08 May 2008 02:00:00 PDT
For the first time, researchers from the University of Pittsburgh School of Medicine have identified genetic components of dendritic cells that are key to asthma and allergy-related immune response malfunction. Targeting these elements could result in more effective drugs to treat allergic disorders and asthma, according to a study reported in the May edition of the journal Nature Medicine.
House Of Lords To Debate Science Committee Allergy Report, UK published
Thu, 08 May 2008 01:00:00 PDT
The House of Lords will on Thursday 8 May debate the Science and Technology Committee's report on Allergy which was published in September last year. The Government responded to the report in November and accepted many of the Committee's recommendations. The debate will give the Committee the opportunity to question the Government on how far they have got in implementing these recommendations.
On The Road With Allergies And Asthma published
Tue, 06 May 2008 04:00:00 PDT
For millions of Americans with allergies and asthma, summer travel concerns extend far beyond rising gas prices and airline security waits.The American Academy of Allergy, Asthma & Immunology (AAAAI) estimates that more than 20 million Americans have asthma and 50 million have allergies. Those traveling this summer will face unique challenges."Vacations bring people outdoors to explore new sights or enjoy the weather.
April Showers Bring May Flowers... And Kick Allergy Season Into Full Bloom published
Mon, 05 May 2008 00:00:00 PDT
May is National Asthma and Allergy Awareness Month, and Carpenter Co., a leader in sleep technologies and the world's largest producer of comfort cushion products, offers relief for the more than 60 million Americans who suffer from these ailments. The company's innovative SlumberFresh™ pillow is filled with RELY™ fiber, which protects the pillow and mattress pad against known allergens such as mold, mildew, fungus and the odors they cause.
Peanut Allergy Immunotherapy Should Be Available In Five Years published
Sun, 04 May 2008 00:00:00 PDT
Some form of immunotherapy is expected to be available for peanut allergy within the next five years. But the reasons for the increasing prevalence of this allergic reaction remain unclear. The issues are discussed by Professor Wesley Burks, Duke University Medical Center, NC, USA, in a Seminar in this week's edition of The Lancet.
ISTA Pharmaceuticals Announces New Phase III Clinical Findings To Support Bepreve NDA Filing published
Thu, 01 May 2008 00:00:00 PDT
ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA), announced positive results from the preliminary analysis of its second and final Bepreve(TM) (bepotastine ophthalmic solution) Phase III clinical study. The U.S. multi-center conjunctival allergen challenge (CAC) study evaluated the onset and duration of effect of two Bepreve concentrations in 130 patients with a history of ocular allergies.
Lexington Is USA's Worst City For Allergy Sufferers published
Sat, 26 Apr 2008 10:00:00 PDT
According to the Asthma and Allergy Foundation of America (AAFA), Lexington, Kentucky, is the worst city for allergy sufferers in the USA. The AAFA has issued the 2008 Rank - Rankings for the Allergy Capitals, which lists the top 100 cities for allergies. Greensboro, N.C.; Johnson City, Tenn.; Augusta, Ga.; and Jackson, Miss. Follow Lexington in the top five. Spokane, Wash.; San Francisco, Cal.; Bakersfield, Cal.; Sarasota, Fla.; and Lancaster, Penn.
Inspire To Discontinue Development Of Epinastine Nasal Spray published
Fri, 25 Apr 2008 02:00:00 PDT
Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH) announced that its Phase 3 trial with epinastine nasal spray for the treatment of seasonal allergic rhinitis (SAR) did not meet its primary endpoint. "Our analysis of the overall data in this program and the current competitive environment in allergic rhinitis indicate that epinastine nasal spray does not show potential to meet our desired product profile in the United States," stated Christy L. Shaffer, Ph.D.
FDA Clears Glove Made From New Type Of Latex published
Thu, 24 Apr 2008 04:00:00 PDT
The U.S. Food and Drug Administration has cleared for marketing the first device made from a new form of natural rubber latex, guayule latex. The product, the Yulex Patient Examination Glove, is derived from the guayule bush, a desert plant native to the Southwestern United States.Traditional latex gloves are made from the milky sap of a rubber tree, Hevea braziliensis.
Keep An Eye On Allergies This Season published
Mon, 21 Apr 2008 00:00:00 PDT
An estimated 50 million Americans suffer from the miseries of allergies, with allergic reactions involving the eyes a common complaint. For many, symptoms of eye allergies can be so uncomfortable and irritating that they interfere with job performance, impede leisure-time and sports activities, and curtail vacations.
Evaluating Treatment To Prevent Allergic Reactions To Food published
Fri, 18 Apr 2008 04:00:00 PDT
Researchers at National Jewish Medical and Research Center are conducting trials to evaluate a method to prevent allergic reactions to food. They are feeding peanut- and egg-allergic people increasing doses of an investigational protein extract from the foods to see if they can induce the participants' immune systems to tolerate the food.
Dust Mites Outlast Heroic Efforts To Help Asthma Patients published
Wed, 16 Apr 2008 02:00:00 PDT
Asthma sufferers might as well stop wasting energy and money on labor-intensive or costly interventions to get rid of household dust, according to a new review of studies."We can conclude with confidence that there is no need to buy expensive vacuum cleaners or mattress covers or to use chemical methods against house dust mites, because these treatments do not work," said lead author Peter Gotzsche, M.D.
New International Field Of Research Established - Allergooncology published
Wed, 16 Apr 2008 02:00:00 PDT
Research into the correlations between allergies and the development of tumours - and possible benefits for future cancer treatments - has finally become an established research discipline in its own right. That was the conclusion at the 2nd International AllergoOncology Symposium, which took place in Vienna at the weekend. The symposium's organiser, Prof.
Perrigo Announces Approval For Over The Counter Children's Cetirizine Oral Solution published
Tue, 15 Apr 2008 00:00:00 PDT
Perrigo Company (Nasdaq: PRGO; TASE) announced that it has received final approval from the U.S. Food and Drug Administration to manufacture and market over-the-counter (OTC) Children's Cetirizine Hydrochloride Oral Solution (Allergy) and Children's Cetirizine Hydrochloride Oral Solution (Hives-Relief), 1mg/mL.
From Cancer Vaccines To A Cure For Allergies published
Mon, 14 Apr 2008 15:00:00 PDT
Unlike the world of high-tech, Israel's biotech community is populated with women leading life-changing companies into the new millennium. They are CEOs and business development experts who sniff out new technology possibilities from Israeli academia and then bring them to life. One of these women is Anat Eitan, the founder and CEO of two young biotech startups AllergyFight and VacciGuard.
Five Million Hay Fever Sufferers Putting Health At Risk, UK published
Mon, 14 Apr 2008 05:00:00 PDT
Over five million of the 13 million hay fever sufferers across Britain could be taking inappropriate medicines, putting their health at risk. The Royal Pharmaceutical Society of (RPSGB) is encouraging people experiencing the symptoms of hay fever to visit their community pharmacist after new research revealed that the public often misdiagnose the condition and fail to get the correct treatment.
Autumn Mite Trigger Asthma, Australia published
Tue, 08 Apr 2008 03:00:00 PDT
As the leaves fall, the dust mite population in your bedroom could well be on the rise. Research from Sydney's Woolcock Institute of Medical Research shows that dust mite levels can increase 2-3 fold during late autumn, compared with summer levels.1 According to National Asthma Council Australia director, Dr Janet Rimmer, a respiratory physician and allergist, that's bad news for the vast numbers of Aussies with dust-mite triggered allergy or asthma.
Avoid Allergens To Reap The Rewards Of Gardening published
Mon, 07 Apr 2008 04:00:00 PDT
The beauty of budding plants and bouquet of aromas are sources of satisfaction for many gardeners. For allergy sufferers, though, gardening can be as much a chore as pursuit of passion. Pollen from trees, shrub and grasses can cause an onslaught of allergy symptoms, including sneezing, itchy eyes, congestion and in some cases, an asthma attack.
Is Champagne Allergen Free?... published
Mon, 07 Apr 2008 01:00:00 PDT
Is champagne allergen free? Well, it certainly is if you have a yeast sensitivity. In the April issue of Foods Matter, the UK's only magazine for those with allergies or intolerances - Hayley Tink examines potential allergens in wine and how to avoid them. Plus - the practical management of atopic eczema in children - and research reports, allergen free recipes and product assessments.
Rite Aid Pharmacists Can Help Patients Breathe Easier, Manage Symptoms And Find Relief This Allergy Season published
Thu, 03 Apr 2008 04:00:00 PDT
According to the American Academy of Allergy, Asthma & Immunology, more than 50 million Americans spend their spring season coughing, itching and sneezing, thanks to allergies. For those seeking relief, Rite Aid pharmacies nationwide have launched a two-month comprehensive initiative to help seasonal allergy sufferers understand and manage their reactions to allergens and survive the season.
Joint Statement On FDA Investigation Of Singulair From The AAAAI And ACAAI published
Mon, 31 Mar 2008 04:00:00 PDT
Leadership from the American Academy of Allergy Asthma & Immunology and the American College of Allergy, Asthma & Immunology released the following statement in response to the Thursday announcement of a Food and Drug Administration investigation into Singulair:There are no data from well-designed studies to indicate a link between Singulair and suicide.
Troublesome Allergens Thrive In Humid Weather published
Fri, 28 Mar 2008 00:00:00 PDT
About 40 million Americans suffer from "hay fever," a disease that allergists prefer to call "allergic rhinitis," because HAY is not to blame and FEVER is rarely a symptom.
Cedars-Sinai Pulmonologist Offers Commonsense Advice On Coping With A Prolific Allergy Season In California published
Tue, 25 Mar 2008 04:00:00 PDT
California's generous winter rains have set the stage for a spectacularly lush spring-and a potentially severe allergy season, says Zab Mosenifar, M.D., medical director, Women's Guild Lung Institute at Cedars-Sinai Medical Center. "The trails are magnificent," notes the longtime mountain runner, who just completed his 26th Catalina Marathon. "I'd never seen the flowers I saw along the Santa Monica trails this season. The landscape is absolutely luscious.
Auriga Laboratories Announces The Launch Of Extendryl(R) PEM And Extendryl(R) GCP published
Mon, 24 Mar 2008 11:00:00 PDT
Auriga Laboratories, Inc. (OTCBB: ARGA), a specialty pharmaceutical company, announced today the launch of Extendryl® PEM and Extendryl® GCP. The two new products will be marketed under the Extendryl brand name which consists of prescription products to treat various cough, cold, and allergy symptoms. The prescription respiratory market is valued at more than 8 billion dollars in sales and more than 68 million prescriptions are written annually in the US.
Dr. Hugh A. Sampson Elected President Of The American Academy Of Allergy, Asthma & Immunology (AAAAI) published
Mon, 24 Mar 2008 02:00:00 PDT
Hugh A. Sampson, MD, FAAAAI, was elected President of the American Academy of Allergy, Asthma & Immunology (AAAAI) during its 2008 Annual Meeting in Philadelphia. He will serve as President through March 2009. The AAAAI is the largest professional medical specialty organization in the United States representing allergists, asthma specialists, clinical immunologists, allied health professionals and others with a special interest in the research and treatment of allergic disease.
)
|
|
